All translations
Jump to navigation
Jump to search
Enter a message name below to show all available translations.
Found 2 translations.
| Name | Current message text |
|---|---|
| h English (en) | == Further reading == * {{cite journal | vauthors = Udpa N, Million RP | title = Monoclonal antibody biosimilars | journal = Nature Reviews. Drug Discovery | volume = 15 | issue = 1 | pages = 13–4 | date = January 2016 | pmid = 26678619 | doi = 10.1038/nrd.2015.12 | s2cid = 27954836 }} * {{cite journal | vauthors = Jelkmann W | title = Biosimilar epoetins and other "follow-on" biologics: update on the European experiences | journal = American Journal of Hematology | volume = 85 | issue = 10 | pages = 771–80 | date = October 2010 | pmid = 20706990 | doi = 10.1002/ajh.21805 | s2cid = 205293428 | url = https://hal.archives-ouvertes.fr/hal-00552331/document | doi-access = free }} |
| h Japanese (ja) | == さらに読む == * {{cite journal | vauthors = Udpa N, Million RP | title = Monoclonal antibody biosimilars | journal = Nature Reviews. Drug Discovery | volume = 15 | issue = 1 | pages = 13–4 | date = January 2016 | pmid = 26678619 | doi = 10.1038/nrd.2015.12 | s2cid = 27954836 }} * {{cite journal | vauthors = Jelkmann W | title = Biosimilar epoetins and other "follow-on" biologics: update on the European experiences | journal = American Journal of Hematology | volume = 85 | issue = 10 | pages = 771–80 | date = October 2010 | pmid = 20706990 | doi = 10.1002/ajh.21805 | s2cid = 205293428 | url = https://hal.archives-ouvertes.fr/hal-00552331/document | doi-access = free }} |